The role of microglia and macrophages in the development of brain tumors

小胶质细胞和巨噬细胞在脑肿瘤发生中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Project Summary: This proposal describes a 5-year-long career development program whose goal is to prepare Dr. Phillips for the role of an independent academic investigator. The project sponsor, Dr. Zena Werb, will provide the principle guidance. Dr. Werb is an internationally recognized expert on the tumor microenvironment and has a distinguished record of training independent scientists. The project co-sponsor, Dr. David Rowitch, is an internationally recognized expert on brain tumor development with a demonstrated commitment to training clinician-scientists. In addition to Drs. Werb and Rowitch, the members of the advisory committee will provide additional scientific and career development related guidance. The research program will address the hypothesis that microglia and macrophages accelerate brain tumor progression and infiltration. Microglia and macrophages are a significant component of the brain tumor microenvironment; however, their activation phenotype and function are unclear. In this project, the role of microglia and macrophages in the development of infiltrating glial tumors will be assessed in three specific aims. First, I will examine the activation patterns of microglia and macrophages in infiltrating glial tumors over time. Studies will be performed using a robust murine model for infiltrating glioma and the results will be confirmed in human tumor tissue. Second, I will determine whether microglia and macrophages promote tumor cell infiltration. Using novel imaging technology I will monitor the dynamic interactions of immune cells and tumor cells. Third, I will determine the in vivo significance of the microglial and macrophage response to brain tumor by depleting it or modifying it. The research training will also include a formal didactic program in research ethics, tumor biology, advanced molecular techniques, and tumor immunology. The UCSF Pathology Department is fully committed to Dr. Phillips' career development and UCSF provides an ideal setting for the training of independent physician scientists. Relevance: In 2007, it is estimated that 20,500 individuals will be diagnosed with cancer of the brain and nervous system in the United States. Despite current therapies infiltrating gliomas, the most common type of primary brain tumor, continues to progress and is often fatal. The research proposed in this project will yield important insight into the factors in the microenvironment that contribute to brain tumor progression and infiltration and potentially may aid in the development of new therapies for glioma.
描述(由申请人提供):项目摘要:本提案描述了一个为期5年的职业发展计划,其目标是为菲利普斯博士担任独立学术调查员做好准备。项目发起人Zena Werb博士将提供原则指导。Werb博士是国际公认的肿瘤微环境专家,在培训独立科学家方面有着杰出的记录。该项目的共同发起人大卫罗维奇博士是国际公认的脑肿瘤发展专家,致力于培训临床科学家。除了Werb和Rowich博士,咨询委员会的成员将提供额外的科学和职业发展相关的指导。该研究计划将解决小胶质细胞和巨噬细胞加速脑肿瘤进展和浸润的假设。小胶质细胞和巨噬细胞是脑肿瘤微环境的重要组成部分;然而,它们的活化表型和功能尚不清楚。在这个项目中,小胶质细胞和巨噬细胞在浸润性神经胶质肿瘤的发展中的作用将在三个特定的目标进行评估。首先,我将研究浸润性神经胶质瘤中小胶质细胞和巨噬细胞随时间的激活模式。将使用稳健的浸润性胶质瘤鼠模型进行研究,并将在人肿瘤组织中确认结果。其次,我将确定小胶质细胞和巨噬细胞是否促进肿瘤细胞浸润。使用新的成像技术,我将监测免疫细胞和肿瘤细胞的动态相互作用。第三,我将通过减少或改变小胶质细胞和巨噬细胞对脑肿瘤的反应来确定其在体内的意义。研究培训还将包括研究伦理学,肿瘤生物学,先进分子技术和肿瘤免疫学的正式教学计划。UCSF病理学系完全致力于菲利普斯博士的职业发展,UCSF为独立医生科学家的培训提供了理想的环境。相关性:据估计,2007年,美国将有20,500人被诊断患有脑癌和神经系统癌。尽管目前的治疗浸润性神经胶质瘤,最常见的原发性脑肿瘤类型,继续进展,往往是致命的。该项目中提出的研究将对微环境中有助于脑肿瘤进展和浸润的因素产生重要的见解,并可能有助于开发神经胶质瘤的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joanna Phillips其他文献

Joanna Phillips的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joanna Phillips', 18)}}的其他基金

Immune Monitoring and Biospecimen Core
免疫监测和生物样本核心
  • 批准号:
    10689798
  • 财政年份:
    2021
  • 资助金额:
    $ 16.14万
  • 项目类别:
Immune Monitoring and Biospecimen Core
免疫监测和生物样本核心
  • 批准号:
    10487525
  • 财政年份:
    2021
  • 资助金额:
    $ 16.14万
  • 项目类别:
Immune Monitoring and Biospecimen Core
免疫监测和生物样本核心
  • 批准号:
    10305131
  • 财政年份:
    2021
  • 资助金额:
    $ 16.14万
  • 项目类别:
Mitigation of preanalytic factors influencing brain tumor protein phosphorylation
减轻影响脑肿瘤蛋白磷酸化的分析前因素
  • 批准号:
    10581567
  • 财政年份:
    2019
  • 资助金额:
    $ 16.14万
  • 项目类别:
Mitigation of preanalytic factors influencing brain tumor protein phosphorylation
减轻影响脑肿瘤蛋白磷酸化的分析前因素
  • 批准号:
    10369600
  • 财政年份:
    2019
  • 资助金额:
    $ 16.14万
  • 项目类别:
Mitigation of preanalytic factors influencing brain tumor protein phosphorylation
减轻影响脑肿瘤蛋白磷酸化的分析前因素
  • 批准号:
    9899209
  • 财政年份:
    2019
  • 资助金额:
    $ 16.14万
  • 项目类别:
Heparan sulfate proteoglycans as critical regulators of brain cancer malignancy
硫酸乙酰肝素蛋白多糖作为脑癌恶性肿瘤的关键调节因子
  • 批准号:
    9096898
  • 财政年份:
    2012
  • 资助金额:
    $ 16.14万
  • 项目类别:
Heparan sulfate proteoglycans as critical regulators of brain cancer malignancy
硫酸乙酰肝素蛋白多糖作为脑癌恶性肿瘤的关键调节因子
  • 批准号:
    8421190
  • 财政年份:
    2012
  • 资助金额:
    $ 16.14万
  • 项目类别:
Heparan sulfate proteoglycans as critical regulators of brain cancer malignancy
硫酸乙酰肝素蛋白多糖作为脑癌恶性肿瘤的关键调节因子
  • 批准号:
    8551786
  • 财政年份:
    2012
  • 资助金额:
    $ 16.14万
  • 项目类别:
Imaging and Tissue Procurement Core
成像和组织采购核心
  • 批准号:
    8741087
  • 财政年份:
    2011
  • 资助金额:
    $ 16.14万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 16.14万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 16.14万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 16.14万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 16.14万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 16.14万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 16.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了